Diabetes and kidney disease: insult added to injury

Winocour PH. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care. Diabet Med 2018;35:300–5. https://doi.org/10.1111/dme.13564

Hill CJ, Cardwell CR, Maxwell AP, et al. Obesity and kidney disease in type 1 and type 2 diabetes: an analysis of the National Diabetes Audit. Q J Med 2013;106:933–42. https://doi.org/10.1093/qjmed/hct123

Ellam T, Twohig H, Khwaja A. Chronic kidney disease in elderly people: disease or disease label. BMJ 2016;352:h6559. https://doi.org/10.1136/bmj.h6559.

Solini A, Penno G, Bonora E, et al. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc 2013;61:1253–61. https://doi.org/10.1111/jgs.12381

Hill CJ, Cardwell CR, Patterson CC, et al. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the UK National Diabetes Audit. Diabet Med 2014;31:448–54. https://doi.org/10.1111/dme.12312.

De Cosmo S, Viazzi F, Pacilli A, et al. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative. Nephrol Dial Transplant 2015;30:1526–33. https://doi.org/10.1093/ndt/gfv101

Luk AO, Li X, Zhang Y, et al. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry. Diabet Med 2016;33:1230–9. https://doi.org/10.1111/dme.13014

American Diabetes Association. Standards of medical care in diabetes–2018. J Clin Appl Res Educ 2018;41(Suppl 1):S1–156.

Lipscombe L, Booth G, Butalia S, et al. Pharmacological glycaemic management of type 2 diabetes in adults. 2018 Clinical Practice Guidelines. Can J Diabetes 2018;42:S88–103. https://doi.org/10.1016/j.jcjd.2017.10.034

National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. [NG28]. 2015. Available at www.nice.org.uk/guidance/ng28 (accessed June 2018).

KDOQI (Kidney Disease Outcomes Quality Initiative) clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 2012; 60:850–86. https://doi.org/10.1053/j.ajkd.2012.07.005

Bilo H, Coentrao L, Couchard C, et al. Guideline Development Group. Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). Nephrol Dial Transplant 2015;30(Suppl 2):ii1–142. https://doi.org/10.1093/ndt/gfv100

Frankel A, Kazempour-Ardebili S, Bedi R, et al. Management of adults with diabetes on the haemodialysis unit: summary of new guidance from the Joint British Diabetes Societies (JBDS) and the Renal Association. Br J Diabetes 2016;16:69–77. https://doi.org/10.15277/bjd.2016.073

Mark PB, Winocour P, Day C. Management of lipids in adults with diabetes mellitus and nephropathy and/or chronic kidney disease: summary of joint guidance from the Association of British Clinical Diabetologists (ABCD) and the Renal Association (RA). Br J Diabetes 2017;17:64–72. https://doi.org/10.15277/bjd.2017.125

Dasgupta I, Banerjee D, Chowdhury TA, et al. Association of British Clinical Diabetologists (ABCD) and Renal Association clinical guidelines: hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease. Summary of recommendations. Br J Diabetes 2017;17:160–4.

Winocour P, Bain S, Chowdhury TA, et al. Managing hyperglycaemia in patients with diabetes and diabetic nephropathy-chronic kidney disease. Br J Diabetes 2018;18:78-89. https://doi.org/10.15277/bjd.2018.172

Vupputurri S, Kimes TM, Calloway MO, et al. The economic burden of progressive kidney disease among patients with type 2 diabetes. J Diabetes Complications 2014;28:10–16. https://doi.org/0.1016/j.jdiacomp.2013.09.014